| Serial Number | 98220289 |
| Word Mark | FERMATA |
| Filing Date | Thursday, October 12, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, August 27, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 2, 2024 |
| Goods and Services | Providing medical and scientific research information in the field of clinical trials relating to Fabry disease; Scientific research in the nature of conducting clinical trials for others in the field of Fabry disease; Pharmaceutical research and development in the field of Fabry disease |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 16, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Spark Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
| Party Name | Spark Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Philadelphia, PA 19104 |
| Event Date | Event Description |
| Monday, October 16, 2023 | NEW APPLICATION ENTERED |
| Monday, October 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, May 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 12, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 27, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, May 23, 2024 | ASSIGNED TO EXAMINER |